Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Titan Pharmaceuticals Inc (NASDAQ:TTNP)

1.99
Delayed Data
As of 10:34am ET
 +0.0392 / +2.01%
Today’s Change
1.75
Today|||52-Week Range
6.40
-50.27%
Year-to-Date
No recent news for Titan Pharmaceuticals Inc.

Today’s Trading

Previous close1.95
Today’s open1.96
Day’s range1.91 - 2.00
Volume19,482
Average volume (3 months)138,541
Market cap$41.3M
Dividend yield--
Data as of 10:34am ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-375.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+801.56%
P/E ratio15.3
Price/Sales5.70
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...-0.03-1.85%
OREXOrexigen Therapeutic...+0.02+0.77%
CTRVContraVir Pharmaceut...-0.01-2.38%
EBIOEleven Biotherapeuti...+0.00+0.14%
Data as of 11:02am ET, 07/21/2017

Financials

Next reporting dateAugust 16, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$15.1M
Annual profit (last year)$5.1M
Net profit margin34.09%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sunil Bhonsle
Principal Accounting Officer &
VP-Finance
Brian Crowley
Corporate headquarters
South San Francisco, California

Forecasts